首页> 外文会议>NSTI Nanotechnology Conference Expo >Multimodality therapy: Enhancement of melanoma cell death with combination of heat shock protein 90 inhibitor, 17-(Allylamino)-17-demethoxygeldanamycin (17-AAG), and gold nanoparticles in a noninvasive radiofrequency field
【24h】

Multimodality therapy: Enhancement of melanoma cell death with combination of heat shock protein 90 inhibitor, 17-(Allylamino)-17-demethoxygeldanamycin (17-AAG), and gold nanoparticles in a noninvasive radiofrequency field

机译:多模疗法:具有热休克蛋白90抑制剂的组合,17-(allylamino)-17-indethoxygeldanamycin(17-Aag)和无侵入式射频场中的金纳米粒子的增强

获取原文

摘要

Melanoma is the most serious form of skin cancer. Hyperthermia has been attempted as a viable option to treat advanced stage melanoma. However, solid tumors often respond minimally to hyperthermic treatment partly due to the thermo-tolerance induced by chaperons of the heat shock protein family (Hsp). 17-AAG, a Hsp90 inhibitor, is currently being studied in clinical trials as a direct cancer therapeutic agent. We have shown that gold nanoparticles heat cancer cells in a noninvasive radio frequency (RF) field. Here, we demonstrate the enhancement of melanoma cell death with the tandem treatment based on Hsp90 inhibition and heat therapy using gold nanoparticles in a noninvasive RF field.
机译:黑色素瘤是最严重的皮肤癌形式。热疗被试图作为治疗晚期黑色素瘤的可行选择。然而,由于热休克蛋白家族(HSP)的伴侣诱导的热耐受性,固体肿瘤通常会使高温治疗微量化。目前正在临床试验中研究17-AAG,其HSP90抑制剂是直接癌症治疗剂的临床试验。我们已经表明,金纳米粒子在非侵入式射频(RF)场中的热癌细胞。在这里,我们证明了基于HSP90抑制和热疗法在非侵入性RF场中的金纳米颗粒的串联处理来增强黑色素瘤细胞死亡。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号